NEA Management Company as of June 30, 2019
Portfolio Holdings for NEA Management Company
NEA Management Company holds 44 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ra Pharmaceuticals | 12.9 | $185M | 6.1M | 30.07 | |
| Glycomimetics (GLYC) | 7.6 | $108M | 9.1M | 11.92 | |
| Rhythm Pharmaceuticals (RYTM) | 7.6 | $108M | 4.9M | 22.00 | |
| Crispr Therapeutics (CRSP) | 6.9 | $99M | 2.1M | 47.10 | |
| Allakos (ALLK) | 6.9 | $98M | 2.3M | 43.33 | |
| Phasebio Pharmaceuticals (PHASQ) | 6.1 | $87M | 6.6M | 13.12 | |
| Adaptimmune Therapeutics (ADAP) | 4.5 | $64M | 16M | 4.02 | |
| Senseonics Hldgs (SENS) | 4.4 | $63M | 31M | 2.04 | |
| Epizyme | 3.9 | $55M | 4.4M | 12.55 | |
| Obseva Sa | 3.6 | $52M | 4.6M | 11.31 | |
| Mersana Therapeutics (MRSN) | 3.4 | $48M | 12M | 4.05 | |
| Ardelyx (ARDX) | 2.9 | $41M | 15M | 2.69 | |
| Marker Therapeutics Ord | 2.8 | $40M | 5.0M | 7.92 | |
| Synlogic | 2.7 | $39M | 4.2M | 9.10 | |
| Aurinia Pharmaceuticals (AUPH) | 2.4 | $34M | 5.2M | 6.58 | |
| Dermira | 2.4 | $34M | 3.5M | 9.56 | |
| Trevi Therapeutics (TRVI) | 2.3 | $33M | 4.4M | 7.50 | |
| Genocea Biosciences | 2.0 | $28M | 7.2M | 3.92 | |
| Millendo Therapeutics | 1.4 | $20M | 1.8M | 11.56 | |
| Liquidia Technologies (LQDA) | 1.4 | $20M | 2.5M | 8.00 | |
| AVEO Pharmaceuticals | 1.2 | $17M | 25M | 0.67 | |
| Bloom Energy Corp (BE) | 1.1 | $16M | 1.3M | 12.27 | |
| Lexicon Pharmaceuticals (LXRX) | 1.1 | $15M | 2.4M | 6.29 | |
| Affimed Therapeutics B V | 1.0 | $15M | 5.1M | 2.87 | |
| Mei Pharma | 1.0 | $14M | 5.7M | 2.50 | |
| Strongbridge Bioph shs usd | 0.9 | $13M | 4.1M | 3.13 | |
| Dasan Zhone Solutions | 0.9 | $12M | 956k | 12.99 | |
| Champions Oncology (CSBR) | 0.9 | $12M | 1.6M | 7.83 | |
| Surface Oncology | 0.7 | $9.3M | 3.3M | 2.82 | |
| Rigel Pharmaceuticals (RIGL) | 0.6 | $8.5M | 3.2M | 2.61 | |
| Verona Pharma Plc ads (VRNA) | 0.4 | $6.2M | 1.2M | 5.10 | |
| Proteostasis Therapeutics In | 0.4 | $5.4M | 5.6M | 0.98 | |
| X4 Pharmaceuticals (XFOR) | 0.3 | $5.0M | 333k | 15.00 | |
| Erytech Pharma Sa | 0.3 | $4.5M | 625k | 7.15 | |
| Trevena | 0.3 | $3.9M | 3.8M | 1.03 | |
| Cti Biopharma | 0.2 | $3.2M | 3.8M | 0.86 | |
| Regulus Therapeutics | 0.2 | $2.6M | 2.1M | 1.25 | |
| Tracon Pharmaceuticals | 0.2 | $2.4M | 3.5M | 0.68 | |
| Endologix | 0.1 | $1.8M | 249k | 7.24 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.8M | 183k | 9.86 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $948k | 1.3M | 0.73 | |
| Akari Therapeutics | 0.1 | $913k | 452k | 2.02 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $693k | 2.1M | 0.33 | |
| Achaogen | 0.0 | $104k | 5.2M | 0.02 |
